Over half of UK adults fully vaccinated

Last week, the Medicines and Healthcare products Regulatory Agency (MHRA) authorised Janssen’s COVID-19 vaccine for use in the UK. It is expected to be available for use later this year…reports Asian Lite News.

More than half of all adults in the UK have received a second dose of a COVID-19 vaccine, according to the latest figures published on Thursday.

Health services across the UK have now administered a total of 66,180,731 vaccines between 8 December and 2 June, including 39,758,428 people with first doses (75.5%) and 26,422,303 people with both doses (50.2%).

A recent study by Public Health England (PHE) shows that 2 doses of the COVID-19 vaccines are highly effective against the B.1.617.2 (Delta) variant first identified in India.

We know how important the second dose is to give protection, particularly against the Delta variant,” Heath Secretary Matt Hancock said. “That’s why we’ve brought forward appointments from 12 to 8 weeks for the most vulnerable people.”

“I encourage everyone who is eligible to join the millions who have the fullest possible protection from this virus,” he added.

Last week, the Medicines and Healthcare products Regulatory Agency (MHRA) authorised Janssen’s COVID-19 vaccine for use in the UK. It is expected to be available for use later this year.

The single-dose vaccine was shown to be 67% effective overall in preventing COVID-19 infection and 85% effective in preventing severe disease or hospitalisation.

Vaccines Minister, Nadhim Zahawi also invited people to comeback for the second jab.

“Everyone who has received their second dose can breathe a huge sigh of relief knowing that they have ultimate protection from the virus and the new variants,” he said.

“We have come an incredibly long way in just under 6 months with our vaccination programme. But our work is not done yet. If you’ve had one dose, please come back for your second jab when you get the offer,” he added.

ALSO READ-60 million vaccine doses administered in UK

READ MORE-UK approves single-dose J&J Covid vaccine